Skip to content

KORU Medical Systems KRMD Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)

Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies

Baxter International logo
Baxter InternationalBAX
UFP Technologies logo
UFP TechnologiesUFPT
Dover logo
DoverDOV

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's total cash, cash equivalents, and restricted cash (inclusive).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's total cash, cash equivalents, and restricted cash (inclusive)?
KORU Medical Systems (KRMD) reported total cash, cash equivalents, and restricted cash (inclusive) of $8.77M in Q1 2026.
How has KORU Medical Systems's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
KORU Medical Systems's total cash, cash equivalents, and restricted cash (inclusive) increased by 0.4% year-over-year, from $8.74M to $8.77M.
What is the long-term trend for KORU Medical Systems's total cash, cash equivalents, and restricted cash (inclusive)?
Over 4 years (2021 to 2025), KORU Medical Systems's total cash, cash equivalents, and restricted cash (inclusive) has grown at a -23.1% compound annual growth rate (CAGR), from $25.33M to $8.87M.
What does total cash, cash equivalents, and restricted cash (inclusive) mean?
This represents the total liquidity available to the company, including cash on hand, highly liquid cash equivalents, and restricted cash balances. It encompasses all cash resources, including those associated with discontinued operations or disposal groups. This is a primary indicator of the company's ability to meet immediate financial obligations and fund ongoing operations.